METEOR: Aiming at the stars for asymptomatic carotid artery atherosclerosis?

International Journal of Clinical Practice

Volumn 61, Issue 8, 2007, Pages 1242-1246

  Paraskevas, Kosmas I ^a   Wierzbicki, Anthony S ^b   Mikhailidis, D P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; WARFARIN;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; EDITORIAL; HUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CLINICAL TRIALS AS TOPIC; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIMIDINES; SULFONAMIDES;

EID: 34447313089     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01483.x     Document Type: Editorial

References (20)

1. Salonen R, Nyyssonen K, Porkkala E et al., Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995 92 : 1758 64.
2. Hodis HN, Mack WJ, LaBree L et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996 124 : 548 56.
3. Mercuri M, Bond MG, Sirtori CR et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 1996 101 : 627 34.
4. Hedblad B, Wikstrand J, Janzon L et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness. Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001 103 : 1721 6.
5. Reid JA, Wolsley C, Lau LL et al. The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg 2005 30 : 464 8.
6. Anderssen SA, Hjelstuen AK, Hjermann I et al. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Atherosclerosis 2005 178 : 387 97.
7. Byington RP, Evans GW, Espeland MA et al. Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1999 100 : e14 7.
8. Crouse JR 3rd., Raichlen JS, Riley WA et al, METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007 297 : 1344 53.
9. Crouse JR 3rd., Grobbee DE, O'Leary DH et al., METEOR Study Group. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study. Curr Med Res Opin 2007 23 : 641 8.
10. Lauer MS. Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk. JAMA 2007 297 : 1376 8.
11. Amarenco P, Bogousslavsky J, Callahan A 3rd. et al., Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 355 : 549 59.
12. Centers for Disease Control and Prevention (CDC). Place of death after stroke - United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2006 55 : 529 32.
13. Ingall T. Stroke - incidence, mortality, morbidity and risk. J Insur Med 2004 36 : 143 52.
14. British National Formulary (BNF 53). http://www.bnf.org/bnf/bnf/current/ 128043.htm (accessed March 2007).
15. RxUSA New York State Registered Pharmacy. http://rxusa.com/cgi-bin2/db/ db.cgi?name2=CRESTOR (accessed March 2007).
16. Guidelines of the National Institute for Health and Clinical Excellence. http://guidance.nice.org.uk/TA94/guidance/pdf/English (accessed April 2007).
17. Baigent C, Keech A, Kearney PM et al, Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005 366 : 1267 78.
18. Cannon CP, Steinberg BA, Murphy SA et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006 48 : 438 45.
19. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg 2007 (in press).
20. Espeland MA, Applegate W, Furberg CD et al., for the ACAPS Investigators. Estrogen replacement therapy and the progression of intimal-medial thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 1995 142 : 1011 19.